Transdermal Nicotine has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Varenicline, Varenicline Tartrate. Patients taking Transdermal Nicotine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 2
Major (2)
- Transdermal Nicotine + Varenicline— Coadministration resulted in high rate of discontinuation due to adverse events (nausea, headache, vomiting, dizziness, …
- Transdermal Nicotine + Varenicline Tartrate— Combination resulted in increased adverse events (nausea, headache, vomiting, dizziness, dyspepsia, fatigue) with 36% di…